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Abstract
Background: Predicting progression from Mild Cognitive Impairment (MCI) to Alzheimer’s Disease (AD) is an
utmost open issue in AD-related research. Neuropsychological assessment has proven to be useful in identifying MCI
patients who are likely to convert to dementia. However, the large battery of neuropsychological tests (NPTs)
performed in clinical practice and the limited number of training examples are challenge to machine learning
when learning prognostic models. In this context, it is paramount to pursue approaches that effectively seek
for reduced sets of relevant features. Subsets of NPTs from which prognostic models can be learnt should
not only be good predictors, but also stable, promoting generalizable and explainable models.
Methods: We propose a feature selection (FS) ensemble combining stability and predictability to choose the
most relevant NPTs for prognostic prediction in AD. First, we combine the outcome of multiple (filter and
embedded) FS methods. Then, we use a wrapper-based approach optimizing both stability and predictability
to compute the number of selected features. We use two large prospective studies (ADNI and the Portuguese
Cognitive Complaints Cohort, CCC) to evaluate the approach and assess the predictive value of a large number of NPTs.
Results: The best subsets of features include approximately 30 and 20 (from the original 79 and 40) features, for ADNI
and CCC data, respectively, yielding stability above 0.89 and 0.95, and AUC above 0.87 and 0.82. Most NPTs learnt using
the proposed feature selection ensemble have been identified in the literature as strong predictors of conversion from
MCI to AD.
Conclusions: The FS ensemble approach was able to 1) identify subsets of stable and relevant predictors from
a consensus of multiple FS methods using baseline NPTs and 2) learn reliable prognostic models of conversion from
MCI to AD using these subsets of features. The machine learning models learnt from these features outperformed the
models trained without FS and achieved competitive results when compared to commonly used FS algorithms.
Furthermore, the selected features are derived from a consensus of methods thus being more robust, while releasing
users from choosing the most appropriate FS method to be used in their classification task.
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Introduction
Alzheimer’s disease (AD) is a neurodegenerative disorder
with devastating effects on patients and their families
and the leading cause of dementia [1]. The first symp-
tom is frequently, but not always, difficulty in remem-
bering new information, but progressive cognitive and
functional decline follows [1]. On advanced stages, pa-
tients become unable to complete basic daily life activ-
ities, such as dressing, eating, and personal care [1].
Unfortunately, no treatment is available to revert or at-
tenuate disease progression. Nowadays, more than 30
million people suffer from AD worldwide and its preva-
lence is expected to triple by 2050 [2], mainly due to
population ageing. Although dementia affects mostly
older people, there is a growing awareness of cases start-
ing before the age of 65 [3]. Being one of the costliest
chronic diseases, these numbers represent not only a
true global epidemic, but also a huge socio-economic
burden to modern societies [4]. Mild Cognitive Impair-
ment (MCI) is considered a transition stage between
healthy aging and dementia. MCI patients have cognitive
complaints not interfering significantly with daily life ac-
tivities. These patients are more likely to develop AD
[5]. In this context, reliably predicting conversion of
MCI to AD can help physicians to take decisions con-
cerning patients’ treatment, patients’ participation in
cognitive rehabilitation programs, and patients’ selection
for clinical trials with novel drugs.
The last decades witnessed a boost in the emergence
of machine learning approaches applied to AD-related
research, recognized as powerful techniques to improve
diagnostic and prognostic [6–13]. However, when ana-
lyzing clinical data, machine learning faces the challenge
of learning from data with a large number of features
and a reduced number of learning examples. Data is
high dimensional and often heterogeneous leading to the
well-known curse-of-dimensionality problem [14]. In
this context, feature selection (FS), a data preprocessing
procedure, is broadly used for dimensionality reduction
[15–18]. Feature selection identifies subsets of relevant
features, preserving (and putatively enhancing) the dis-
criminative capability of the original set of features [16].
On the one hand, FS removes irrelevant features dimin-
ishing noise from data. On the other hand, using a
smaller number of features reduces model complexity
and prevents overfitting, improving learning perform-
ance by promoting generalization [16].
Feature selection algorithms may be categorized into
three main classes: filter, wrapper, and embedded
methods [15, 17]. The main difference between them re-
lies on whether or not a learning algorithm is included
in the selection process. Filter methods evaluate feature
worth based on general characteristics of data (such as
feature correlation) and are therefore independent of
any learning algorithm. Wrapper methods, on the other
hand, rely on the performance obtained by a given clas-
sifier to assess the importance of a subset of features.
Wrapper methods accomplish better accuracy scores but
are more prone to overfitting and computationally ex-
pensive for high dimensional datasets [17]. Filter
methods are generally more efficient than wrapper
methods although the emergent selected features may
not be optimal to the target learning algorithm. In this
context, embedded methods have been proposed as an
in-between option among the aforementioned methods
[19, 20]. Embedded methods join feature selection with
model learning. As such, despite interacting with the
learning algorithm, they are less computationally costly
than wrapper methods, since no iterative evaluation of
the subsets of features is done. The most widely used
embedded methods are sparse learning based methods
[17], where feature worth depends on the feature coeffi-
cients found to minimize errors while fitting the learning
model. Alternatively to error minimization, stability se-
lection [21] uses subsampling or bootstrapping to esti-
mate the proper amount of regularization [8, 17] and
find feature coefficients.
Regarding the output, feature selection methods can
be classified as subset-based or ranking-based FS
methods [15]. Subset-based FS returns a subset of the
original feature cohort while the ranking-based FS
returns the original feature cohort sorted by their
worthiness (feature ranking).
When predicting conversion from MCI to AD, the
subsets of selected features should fulfill three main req-
uisites in order to be useful in clinical practice: 1) con-
tain the most discriminative features independently of
the FS algorithm used, 2) be robust to small data varia-
tions, and 3) be highly predictive of conversion from
MCI to AD. Since there are several FS methods [17],
and each has its own strengths and flaws, deciding
which method is more suitable to the problem at hand
is not trivial, requiring a deep understanding of both
data and FS algorithms. In this scenario, we propose a
feature selection ensemble combining stability and pre-
dictability (classification performance). To tackle 1) and
3) we propose the use of ensemble learning, an approach
that combines the outcome of multiple learners (FS
methods) trained to solve the same problem [18, 22–25].
Regarding 2) we propose to assess feature stability, here
defined as the level of concordance between the subsets
of features selected across the experiments [26].
Ensemble learning is based on the assumption that the
output emergent from a consensus of learning algo-
rithms outperforms that arising from a single method.
In this work, we use heterogeneous ensembles in which
the subsets of features selected by different FS methods
(named base FS methods) are combined into a final
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subset of features [24]. This approach frees users from
deciding the specific FS algorithm to use. Furthermore,
FS results are less prone to be biased by the inherent
characteristics of single FS algorithms and are thus puta-
tively more generalizable. A robust subset of features is
thus expected, as it results from a consensus between FS
methods that rely on distinct search strategies. In this
context, the higher the diversity among base FS methods
the better [27].
Stability assesses the level of agreement between mul-
tiple subsets of features, emergent from different FS
methods, experiments, or changes in data [26]. It is as
important as predictability when users are not only in-
terested in assessing the classification outcome but also
on interpreting the selected features [26, 28, 29]. Despite
the fact that much less attention has been devoted to
the study of stability when compared to the emergence
of FS algorithms, some stability measures have been pro-
posed over the last years [26, 28, 30]. Kuncheva [28] in-
troduced an index that measures stability by modelling
the intersection between two subsets as a hypergeo-
metric distribution. This index is widely used by FS re-
searchers, mainly to compare the similarity between
rankings of features derived by ensemble approaches
[31, 32]. When compared to previously proposed in-
dexes, based on the Jaccard index [33] or the relative
Hamming distance [34], Kuncheva’s index has the ad-
vantage of having the property of correction for chance
[28, 35]. It has, however, the limitation of requiring the
sets of features to have the same cardinality. This issue
shortens its application to ranking methods, where the
number of features to keep is defined by the user (con-
trary to subset-based FS methods where the FS method
controls the number of outputted features). Further
comparison and description of stability measures can be
found in [30, 35].
When seeking for reliable predictors of conversion from
MCI to AD, thus improving prognostic models, powerful
machine learning techniques have been increasingly used.
In the scientific challenge promoted by Kaggle: “A Ma-
chine learning neuroimaging challenge for automated
diagnosis of Mild Cognitive Impairment”, many competi-
tive solutions benefited from complex feature selection
approaches [10, 11, 13]. Nevertheless, despite the value of
such FS approaches they have been mainly applied to neu-
roimaging and biochemical data [8–11, 36–39]. In con-
trast, studies using neuropsychological data, a standard
way to characterize cognitive functioning in a clinical or
research context, tend to rely on traditional statistical
methods, such as regression-based methods (Discriminant
Analysis, for instance) and survival regression models
[40–42]. In this scenario, we believe it is fundamental to
further explore the predictive power of neuropsychological
tests (NPTs) using advanced machine learning techniques.
NPTs are widely used in clinical practice in alternative to
more expensive and often invasive approaches and
achieved competitive results in predicting converting pa-
tients, when compared to biological biomarkers, such as
brain imaging data (MRI and PET) and cerebrospinal fluid
(CSF) [7, 9, 43–45]. Machine learning approaches have
been shown to be more suitable to uncover hidden syner-
gies between a large number of predictors than traditional
statistical methods [46]. Furthermore, finding which NPTs
are the most relevant for prognostic prediction would be
helpful in clinical practice, enabling clinicians to reduce
the number of tests that are performed, saving time, and
potentially reducing the number of missing values in the
NPTs data (occurring due to limitations of interview dur-
ation and patient fatigue), which may compromise the
learning task.
In this paper, we propose a heterogeneous FS ensem-
ble approach to automatically choose subsets of neuro-
psychological predictors of conversion from MCI to AD.
The most relevant features are selected based on the
combination of reduced sets of features learnt from mul-
tiple FS methods, preferentially with different theoretical
foundations. We use ranking-based FS methods. Previ-
ous studies using heterogeneous ensembles [23, 24] dif-
fer from our proposal in what concerns the way multiple
subsets of features are combined and optimized. In our
study, the size of the subsets of features is found by
combining their stability and classification performance.
To our knowledge, it is the first time that stability and
predictability are combined with this purpose in the
context of FS in AD research, using ensemble learning.
We validated the proposed approach using two large
datasets, the Alzheimer’s Disease Neuroimaging Initia-
tive (ADNI) dataset [47] and the Cognitive Cohort Study
(CCC) [48], and the selected neuropsychological predic-
tors were compared in the task of predicting conversion
from MCI to AD. However, we note that the proposed
FS ensemble can be used to select relevant predictors in
other diseases or prognostic problems.
Methods
Figure 1 illustrates the proposed feature selection en-
semble combining stability and predictability (abbrevi-
ated as FSE-StabPred), seeking for a robust, stable, and
highly predictive set of neuropsychological features for
prognostic prediction in MCI. This approach comprises
two phases: 1) finding a subset of features sorted by their
relevance using ensemble learning and 2) optimizing the
subset of feature regarding its stability and predictability.
The learning process follows a cross-validation (CV)
procedure repeated with fold randomization to access
model generalization.
In the first phase, training data (within each fold) is
fed to an ensemble of ranking-based feature selection
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methods. Then, a rank aggregator is used to combine
the rankings of features computed within the ensemble.
A final ranking where features are sorted by their rele-
vance is thus obtained.
In the second phase, a wrapper-based approach is used
to optimize the size of the subset of features. Specifically,
the classifier is run using an incremental subset of fea-
tures including the top-ranked k features, where k ranges
from 1 to the total number of features, m. The stability
of these subsets of features, as well as the classification
performance of the machine learning models (classifiers)
learnt with these features are computed and averaged
across CV-folds and fold randomization repetition. A
threshold is then computed using these values of stabil-
ity and classification performance to set the optimal size
of the subset of features.
The optimal subset of features can vary with the classi-
fier used to assess predictability. In this context, the pro-
posed FS ensemble can be (optionally) run with multiple
classifiers in an ensemble-based approach (Fig. 2). The
emergent subsets of features are then combined in the
aggregator, which selects the pair of features and classi-
fier that yields the highest classification and/or stability
performance. Such classifier is considered the most ap-
propriate to learn the features of the data under study.
The proposed approach was tested in three clinically
relevant time windows of conversion from MCI to AD.
Differences and similarities between subsets of features
(predictors) found for each time window (2, 3, and 4
years time windows) were studied.
Each step of the proposed FS ensemble approach is
described in detail in the following subsections. We first
describe data: ADNI and CCC. Then, we revise the pro-
cedure of creating learning examples using the Time
Windows approach, first proposed in [12]. Follows a de-
scription of the main steps to learn the best features
using an FS ensemble and a wrapper optimization of fea-
tures combining stability and predictability. Finally, an
Fig. 1 Workflow of the proposed feature selection ensemble approach combining stability and predictability (FSE-StabPred)
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ensemble-based approach to learn subsets of features
with different classifiers is described.
Data
Participants were selected from two large prospective
studies: the ADNI project (http://adni.loni.usc.edu/) [47]
and the Cognitive Complaints Cohort (CCC) [48]. Par-
ticipants with clinical diagnosis of MCI at the baseline
(first) assessment and who had at least one follow-up as-
sessment were chosen. Demographic and neuropsycho-
logical data from different cognitive domains were
selected in both datasets. Table A.1 shows the complete
list of neuropsychological tests used in this work along
with the respective mean average and missing values
percentage for each dataset (ADNI and CCC) [See
Additional file 1].
ADNI
ADNI was launched in 2003 as a public-private partner-
ship led by Principal Investigator Michael W. Weiner
[47]. Its goal is to find relevant biomarkers in all stages
of AD to guide future clinical trials for new possible
treatments. ADNI includes several biomarkers of Alzhei-
mer’s disease beyond neuropsychological tests, such as
cerebrospinal fluid, structural Magnetic Resonance Im-
aging (MRI), functional-MRI, Positron Emission Tomog-
raphy, and other biological data. Data is collected from
every ADNI participant at the baseline assessment, as
well as annual follow-up consultations. Written in-
formed consent was obtained from all participants and/
or authorized representatives before protocol-specific
procedures were carried out. This study was approved
by ethical review boards in each participating institution.
Participants were diagnosed with Mild Cognitive Impair-
ment in the presence of a self-report (or via an inform-
ant) memory complaints without severe interference on
daily live activities, objective memory deficit and absence
of significant impairment on non-memory cognitive do-
mains and of dementia. The NINCDS/ADRDA criteria
were used to classify patients with probable AD.
In this work, we used 79 demographic and neuro-
psychological features from ADNI-2 patients (accessed
in June 2017). NPTs include, but are not limited to, the
Mini Mental State Examination (MMSE), the Alzhei-
mer’s Disease Assessment Scale – cognitive subscale
(ADAS-Cog), Clinical Dementia Rating (CDR) scale and
Functional Assessment Questionnaire (FAQ). Table A.1
shows the complete list of features used in this study
[See Additional file 1]. A total of 433 patients were ana-
lyzed: 122 MCI patients converted to dementia in a
follow-up of 4 years while 311 preserved the MCI diag-
nostic for at least 2 years.
Cognitive complaints cohort
The Cognitive Complaints Cohort is a prospective study
conducted at the Faculty of Medicine of Lisbon that re-
cruits subjects with cognitive complaints, referred for a
comprehensive neuropsychological assessment, with the
aim of investigating their progression to dementia. The
study was approved by the local ethics committee and
all participants gave their written informed consent. The
inclusion criteria for admission to CCC were the pres-
ence of cognitive complaints and undergoing a cognitive
assessment with a neuropsychological battery designed
Fig. 2 Workflow of the ensemble-based approach of the proposed FS ensemble combining stability and predictability (FSE-StabPred) using
different classifiers
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to evaluate multiple cognitive domains and validated for
the Portuguese population (Bateria de Lisboa para Ava-
liação das Demências – BLAD [49]). Participants were
excluded from CCC if diagnosed with dementia (accord-
ing to DSM-IV [50]) or other disorders that may cause
cognitive impairment. Participants were diagnosed with
Mild Cognitive Impairment when fulfilling the criteria of
the MCI Working Group of the European Consortium
on Alzheimer’s disease [51]. The MCI diagnosis could
change to dementia, at follow-up, according to the
DSM-IV [50] criteria. The dataset included 51 features
covering demographic and neuropsychological data [See
full list in Additional file 1]. A total of 584 patients were
analysed: 175 MCI patients converted to dementia in a
follow-up of 4 years while 409 preserved the MCI diag-
nostic for at least 2 years.
Creating learning examples using time windows
Progression to dementia is characterized by a continuum
cognitive, functional, and physical decline, which may last
for decades [52]. MCI lies somewhere in this neurodegen-
erative process and thus passes throughout different stages
of the disease. This leads to heterogeneous cohorts of
MCI patients, which, if not considered, may affect the reli-
ability of the prognostic models [12, 53–56]. In a previous
work [12], we proposed to address the heterogeneity in
MCI cohorts by creating time-homogenous groups re-
garding their time to conversion (named as Time Win-
dows approach), when building the learning examples.
This strategy was shown to improve the performance of
the machine learning models to predict progression from
MCI to dementia when compared to the models trained
with the entire (heterogeneous) cohort of MCI patients. In
this work, we followed the Time Windows strategy to cre-
ate learning examples, which we briefly revise below.
For a given time window (2, 3 and 4 years in this
study) we considered patients that converted to demen-
tia within a predefined interval (using dementia diagno-
sis in one of the follow-up assessments up until the limit
of the window). Those are labeled cMCI (converter
MCI). On the other hand, patients that retained the
MCI diagnosis up until the limit of the window or after-
wards are included in the learning set labelled as sMCI
(stable MCI). It is worth noting that the prognosis refers
to a particular time window and might change if the
considered time span changes. For instance, a given pa-
tient may be sMCI in a smaller window and a converting
learning example in a wider window, using a posterior
follow-up evaluation. Moreover, some cases might be
disregarded if not enough follow-up evaluations are
available, for a given time window. For instance, patients
with the first follow-up assessment at 2.5 years from the
baseline, and with dementia diagnosis, will create a
learning example labelled as cMCI in the 3 (and 4) years
time windows. However, no learning example is created
for the 2-years time window. More details about the
Time Windows approach may be found in [12].
Table 1 shows the proportion of learning examples for
each time window of 2 to 4 years and datasets. These
time windows were selected by pondering the follow-up
length of both cohorts and the attempt to avoid skewed
class proportion.
Table 2 presents demographic characterization data.
Differences among the cohorts of cMCI and sMCI pa-
tients were assessed by independent samples t-tests and
X2 Person Chi-Square test to compare numerical and
categorical measures, respectively. A p-value < 0.05 was
assumed as statistically significant. Converting patients
are older than those who remained MCI on both ADNI
and CCC data. No statistical differences (p > 0.48) were
found in formal education between converting and
non-converting MCI patients from ADNI population.
However, in CCC population, non-converting patients
studied more years than those who converted. ADNI and
CCC populations (sMCI and cMCI) are also statistically
different regarding both age and education (p < 0.002, in-
dependent samples t-test). CCC included a more signifi-
cant number of female participants while men were in the
majority in ADNI. Moreover, ADNI participants were
older and highly educated when compared to CCC
participants.
Learning the best features using an ensemble combining
predictability and stability
Once learning examples are created using the Time
Windows approach, data is divided into c cross-valid-
ation folds (or subsets). Each time, one of the c subsets
is used as testing data while the remaining c-1 subsets
are merged to form the training data. Each learning ex-
ample is used exactly once in the testing data and c-1
times in the training data. Data can be preprocessed to
handle missing values, class imbalance, and dimensional-
ity reduction. The latter is here performed using the pro-
posed FS ensemble approach (Fig. 1, FSE-StabPred).
First, a ranking of features is obtained from a consensus
of different FS methods (Fig. 1, Feature Selection Ensem-
ble). Then, the model is tuned to the training data using,
at a time, the k top-selected features (where k ranges
Table 1 Details on ADNI and CCC datasets for time windows of
2 to 4 years
ADNI CCC
sMCI cMCI sMCI cMCI
2-Year window 311 (78%) 89 (22%) 409 (81%) 96 (19%)
3-Year window 235 (68%) 111 (32%) 310 (68%) 143 (32%)
4-Year window 143 (54%) 122 (46%) 227 (56%) 175 (44%)
Note: sMCI stable MCI, cMCI converter MCI. Class imbalance (per time window)
is shown as % within brackets
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from 1 to the total number of features, m). Scores of sta-
bility and classification performance (evaluated on the
testing data) are then used to compute a threshold
reflecting the quality of each subset of features (Fig. 1,
Wrapper optimization of features combining stability
and predictability). The best subset of features is the one
with the highest RPT threshold.
Feature selection ensemble
The FS ensemble used in this work is based on the het-
erogeneous ensemble approach proposed by Seijo-Pardo
et al. [24]. Multiple rankings of features are created
using different feature selection methods. These rank-
ings of features are then combined into a final ranking
of the most relevant features. By following this approach,
we aim to obtain a robust subset of features as it results
from the combination of methods that rely on distinct
search strategies, that is, features found to be relevant
independently of the technique used during the feature
selection process. The FS ensemble has two steps: 1)
running base feature selection methods and 2) using a
ranking aggregator to combine multiple rankings of
features.
Step 1: Using base feature selection methods to
obtain multiple rankings We used ranking-based fea-
ture selection algorithms with search criteria based on
different metrics, as categorized in [17], to promote the
ensemble diversity. Filter methods were preferred (over
wrapper and embedded methods) since we target re-
duced sets of features independently of the learning al-
gorithm applied afterwards. Moreover, we selected
commonly used feature selection algorithms: ReliefF
[57], Information Gain (MIM), Conditional Mutual In-
formation Maximization (CMIM), Minimum Redun-
dancy Maximum Relevance (MRMR), and Chi-Squared
[58]. However, we also included two embedded methods
used in related works [8, 22, 24]: the pruning-based
method Recursive Feature Elimination using SVM
(SVM-REF) [59] and the sparse learning-based method
using the Logistic Loss (LL21) function via l2, 1 norm
[60] regularizer. Wrapper methods were excluded due to
their strong bias with the learning algorithm and high
computational cost. The first five methods are univariate
while the latter are multivariate methods. A further de-
scription of these FS methods may be found in [17].
Step 2: Using a rank aggregator to combine the
multiple rankings The multiple rankings computed by
the different FS methods included in the ensemble must
be combined into a single ranking using a combination
method, named aggregator. Formally, an ensemble com-
bining n different ranking-based FS methods produces a
set Q = {qj, j = 1,…, n}, where qj is either the ordered
ranking of features (simple ranking) or the weighted or-
dered ranking of features (weighted ranking). Feature
weights range from 0 to 1. The aggregator combines the
weights (or the position in the ranking) of the features
in the multiple rankings by using a relevance criteria.
Arithmetic operations, such as mean, median, or max-
imum values are commonly used [24, 28, 31, 61, 62]. We
used the mean aggregator which selects the average of
the ranking position assigned by the FS methods. Then,
features are sorted by their score into a final ranking.
The higher the score, the more relevant the feature is.
Wrapper optimization of features combining stability and
predictability
A final ranking of features is outputted from the FS en-
semble module (Fig. 1). We assessed the quality of each
subset of features, comprising the k top-ranked features,
in terms of its stability and predictability (classification
performance of the classifiers learnt with such features).
These evaluation metrics are then used to compute a
Table 2 Baseline demographic characterization data
Time window, years ADNI CCC
sMCI cMCI p-value sMCI cMCI p-value
Age, years (M ± SD) 2 73.1 ± 7.8 74.4 ± 7.7 0.182 67.2 ± 8.9 72.5 ± 7.9 < 10–7*
3 72.5 ± 7.6 74.9 ± 7.6 <0.006* 66.6 ± 8.8 72.3 ± 8.2 < 10–10*
4 72.1 ± 7.3 74.8 ± 7.6 <0.004* 65.5 ± 9.1 71.9 ± 8.3 < 10–12*
Formal Education, years (M ± SD) 2 15.9 ± 2.7 16.2 ± 2.7 0.483 10.0 ± 4.7 8.9 ± 5.0 < 10–7*
3 16.2 ± 2.7 16.0 ± 2.7 0.715 10.1 ± 4.8 8.6 ± 4.8 <0.003*
4 16.1 ± 2.8 16.0 ± 2.6 0.895 10.4 ± 4.7 8.8 ± 4.8 <0.001*
Gender (male/female) 2 183/128 48/41 0.408 151/258 39/57 0.499
3 136/99 64/47 0.969 119/191 50/93 0.483
4 82/61 70/52 0.995 85/142 60/115 0.513
Group comparison (converter MCI vs stable MCI) were performed with Independent samples t-tests (Age and Formal Education) and X2 Person Chi-Square test
(Gender). Statistically significant (p < 0.05) are marked with an asterisk (*)
Mean (M) and standard deviation (SD) values are illustrated
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threshold, which reflects the worth of each subset of fea-
tures. This threshold is optimized to find the best subset
size and thus the most relevant features.
Measuring classification performance Predictability is
assessed by combining Area Under the ROC Curve
(AUC) [63], sensitivity (proportion of actual converting
patients (cMCI) who are correctly classified), and speci-
ficity (proportion of non-converting patients (sMCI)
who are correctly identified). We used AUC since it is
widely used in binary classification and is appropriate to
deal with class imbalance. Specificity and sensitivity are
frequently used in clinically-related research. We thus
decided to combine the three evaluation metrics. Classi-
fication performance is given by:
performance ¼ α AUC þ γF Sensitivity; Specificityð Þ
ð1Þ
where α and γ, with α + γ in [0, 1], are parameters that
control the importance given to AUC or to the value
given by FðSensitivity; SpecificityÞ. F is a generic func-
tion to combine sensitivity and specificity scores, which
may be tailored to the purpose of the learning task. In
some application domains, it is critical to particularly
avoid either false positives or false negatives. In this case,
to evaluate the classification model we should focus on
the specificity or sensitivity values, respectively, and
thereby choose F that returns only the respective evalu-
ation metric. AUC is kept in (1) with weight α to guar-
antee an acceptable overall classification performance,
despite the bias introduced by the term γ that targets
the specific evaluation metric (sensitivity or specificity).
If, on the other side, we seek a supervised learning
model as good as possible in discriminating both the
positive and negative classes, we need to optimize both
sensitivity and specificity. Different functions (F ) can be
used to combine these metrics. We use simple arith-
metic operations, such as mean or minimum, for the
sake of interpretability. The minimum operator is suit-
able when one of the evaluation metrics will putatively
perform worse than the other. This may occur in imbal-
anced data, for instance. When optimizing parameters
or assessing the performance of models, the minimum
allows targeting the worst performing evaluation metric,
while guaranteeing that the other metric is at least
equally good. In other words, we are optimizing an over-
all score (RPT or classification performance) while bias-
ing this search to benefit the evaluation metric with the
lowest scores, thus finding a good balance between sen-
sitivity and specificity.
Measuring stability Stability of feature selection may be
understood as its sensitivity to small changes in data,
experiments, or use of different methods [30]. We use
Kuncheva’s index to assess the stability between rankings
of features (3). The similarity (stability) between two sets
of features is given by:
Sim kð Þ ¼ rm−k
2
k m−kð Þ ; ð2Þ
where r represents common features between the two
subsets of features, k is the subset size and m is the total
number of features. The stability over the n subsets of
features derived from the ensemble is given by the aver-
age similarity between those n pairs of features:
Stability ¼ 2
n n−1ð Þ
Xn−1
i¼1
Xn
j¼iþ1 Simi kð Þ; Simj kð Þ
 
:
ð3Þ
This index is bounded by [−1, 1].
Computing the RPT threshold There are different ap-
proaches to find the optimal subset size of a ranking of
features: from keeping a percentage [24, 31, 62], com-
puting the log2(m) or the Fisher’s discriminant ratio of
the total number of features (m) [24, 62, 64], to strat-
egies exploiting the classification error [28]. In this work,
we use the robustness-performance trade-off (RPT), pro-
posed in [22], to find the threshold that optimizes both
the stability of the subset of features and its classification
performance (predictability):
RPT ¼ β
2 þ 1  stability predictability
β2stabilityþ predictability ð4Þ
where β is the parameter controlling the weight given to
stability and classification performance.
Computing the best subset of features with an ensemble-
based approach using different classifiers
The search for the best subset of features relates to the
classifier by means of the predictability in (4). In this
context, we might (optionally) run the proposed FS en-
semble with multiple classifiers and find the pair (fea-
tures, classifier) that better fits the data under study (Fig.
2). In the first step, the FS ensemble approach combin-
ing predictability and stability (FSE-StabPred), described
in Fig. 1, is run with p distinct classifiers. It returns, at
least, p subsets of features (different parameters in (4) may
be tested), which are then combined into a final one in the
aggregator step. The aggregator selects the subset of
features, computed using classifier p, that yields the
maximum performance in a given evaluation metric (RPT,
for instance). Other strategies can, however, be used to
combine the best subsets of features found by each
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classifier p, such as outputting a final subset of features
with the mean size of the p subsets of features.
Classification settings
We used 10 × 5-fold stratified cross-validation and com-
monly used classifiers, relying on different learning ap-
proaches to the classification problem: Gaussian Naïve
Bayes classifier (NB), Decision Tree (DT), Gaussian (SVM
RBF) and Polynomial-kernel (SVM Poly) Support Vector
Machines (SVMs), and Logistic Regression (LR). To deal
with missing values, we removed features with a percent-
age of missing values above 20% and imputed the
remaining using their mean or mode, in case they were
numerical or nominal. This reduced to 40 (from 51) the
number of features to be selected from CCC data while
the original set of features from ADNI was maintained
[See Additional file 1]. In addition, class imbalance was
handled with Synthetic Minority Over-sampling Tech-
nique (SMOTE) [65]. SMOTE performs oversampling of
the minority class with replacement. It creates synthetic
instances by selecting (randomly) a set of instances from
the minority class and perturbing the features by a ran-
dom amount. SMOTE was only used when the class im-
balance was superior to 70%. In order to ensure the
validity of the results, all preprocessing techniques (FS,
missing values imputation, and SMOTE) were applied to
the training data within each cross-validation fold.
The feature selection ensemble was implemented
using seven base FS methods: ReliefF, MIM, CMIM,
MRMR, Chi-Squared, SVM-RFE, and LL21. Once learn-
ing the final rank of features (using the rank mean ag-
gregator), the classifier was run (m times) using, at a
time, the top-k ranked features (k ranging from 1 to the
total number of features, m). This process was repeated
for each round of 5 CV and each 10 iterations and thus,
50 (putatively) different aggregated rankings, and 50 ×m
models, were created. RPT values were then computed
using the performance metrics achieved using these
models. The best subset size is defined as the threshold
that maximizes this threshold. Three β values were tested:
β = 1 (equal weight to stability and classification perform-
ance), β = 0.1 (higher weight to stability) and β = 10
(higher weight to classification performance). Stability was
measured using the index proposed by Kuncheva [28]
while classification performance was assessed according to
(1), where Fðsensitivity; specificityÞ ¼ minðsensitivity;
specificityÞ and α = γ = 0.5 (equal weight to both evalu-
ation metrics). We used the minimum operator since we
aim at finding the number of features that lead to a classi-
fication model as accurate as possible on classifying both
converting and non-converting MCI patients, thus reach-
ing a right balance between sensitivity and specificity.
When running the FS ensemble approach combining sta-
bility and predictability using different classifiers, the
aggregator outputs the pair of features and classifier with
the highest RPT score.
Statistical significance of results was evaluated on the
averaged classification performance given by (1) across
10×5-fold CV. Friedman Tests [66] were used to infer
whether results obtained across different experiments,
such as the base FS methods and the ensemble, or RPT
thresholds with different β values, have statistically sig-
nificant differences. Wilcoxon Signed Rank Tests were
used for pairwise comparisons, with Bonferroni correc-
tion for multiple testing when needed. We used IBM
SPSS Statistics 24 (released version 24.0.0.0) to run the
statistical tests. The feature selection approach was im-
plemented in Python using scikit-learn and the feature
selection algorithms implemented in scikit-feature
(http://featureselection.asu.edu) [17].
The proposed approach is applied to each dataset
(ADNI and CCC) and time window (2, 3 and 4 years).
We note, however, that the described feature selection
approach may be used with any classifier, feature selec-
tion methods, and/or preprocessing options.
Results
This section reports the outcome of the proposed FS en-
semble when applied to ADNI and CCC data using
neuropsychological data. We first analyse ensemble di-
versity concerning the base FS methods included. Fol-
lows an overall evaluation of results obtained with
different classifiers. Then, we evaluate how stability and
predictability vary with the number of top-selected fea-
tures used to learn the prognostic model. Predictive per-
formance of base FS methods is then compared with the
FS ensemble approach. Finally, we discuss the clinical
relevance of top-selected features for each dataset and
time window.
Diversity of FS methods used in the FS ensemble
Ensemble diversity is promoted by using seven algo-
rithms based on different strategies to measure the
worthiness of features. Since we believe that unstable
base FS methods deteriorate the robustness of the en-
semble, we analysed: 1) the stability of base FS methods
individually, to decide whether they should or not join
the ensemble, and 2) the pairwise stability between base
FS methods to appraise ensemble diversity. Table 3
shows the stability score of each base FS method (in the
diagonal) and the pairwise stability of base FS methods
averaged over CV folds, repetitions, and the number of
features (k) using ADNI data. Comparable results were
obtained using CCC data [See Additional file 2] and are
not included in the main text for the sake of readability.
SVM-RFE achieves a maximum individual stability
score of 0.302 (Tables 2, 3-years time window) reflecting
the inconsistency of the correspondent subsets of
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features. It underperforms the remaining FS methods,
whose stability ranged between 0.728 to 0.908. We
thus decided to exclude SVM-RFE from the ensemble.
The highest stability is yielded by LL21, followed by
Chi-squared, MIM, MRMR, ReliefF and CMIM
methods.
The ensemble diversity is supported by the low scores
of pairwise stability which range between 0.237 to 0.704.
The features selected by MRMR are the most inconsist-
ent with the remaining FS methods while LL21 has glo-
bally the highest pairwise stability.
Computing the best subset of features with an
ensemble-based approach using different classifiers
Tables 4 and 5 report the results obtained with the pro-
posed FS ensemble (FSE-StabPred) using different classi-
fiers, for each time window, using ADNI and CCC data,
respectively. We recall that the best subset of features is
that with the highest RPT, computed in the step “Wrap-
per optimization of features combining stability and pre-
dictability”. We tested three β values, when computing
RPT, thus three putatively different subsets of features
are found per classifier.
The number of selected features varies considerably
with the classifier and β used. In this study, it tends to
increase with β, which reflects an increase in the weight
assigned to predictability when computing RPT. When
β = 0.1, the few features outputted by the FS ensemble
are not able to properly classify converting MCI patients,
revealed by the low sensitivity scores, while specificity
yields higher scores. SVMs are particularly affected by
this low number of features, producing the lowest sensi-
tivity scores. However, their performance improves as
the size of the subset of features increases. When using
a larger subset of features, SVMs, NB and LR have simi-
lar classification performances although NB achieves, in
general, a better balance between sensitivity and specifi-
city. We observe that DT, on the other side, is the weak-
est classifier as it attains the poorest results in terms of
classification performance for all time windows and
datasets.
In what concerns the trade-off between stability and
predictability, Naïve Bayes yielded highest RPT scores for
all time windows and datasets, excepting for the 2-years
time windows using ADNI and CCC data, where LR was
superior. Therefore, according to the aggregator of the
ensemble-based approach using different classifiers (which
Table 3 Individual and pairwise stability of the base FS algorithms used in the ensemble. Results are averaged over the 10 × 5 stratified
CV and m subsets (for each possible subset size) for the 2-years (upper values), 3-years (middle values) and 4-years (bottom values), using
ADNI data
ReliefF MIM CMIM MRMR Chi-Squared SVM-RFE LL21
ReliefF 0.784 ± 0.127 – – – – – –
0.755 ± 0.147
0.728 ± 0.158
MIM 0.601 ± 0.192 0.863 ± 0.112 – – – – –
0.589 ± 0.215 0.862 ± 0.108
0.570 ± 0.208 0.861 ± 0.114
CMIM 0.589 ± 0.243 0.704 ± 0.124 0.774 ± 0.152 – – – –
0.533 ± 0.242 0.667 ± 0.139 0.758 ± 0.164
0.479 ± 0.23 0.618 ± 0.168 0.739 ± 0.168
MRMR 0.446 ± 0.211 0.301 ± 0.162 0.396 ± 0.174 0.858 ± 0.054 – – –
0.371 ± 0.176 0.252 ± 0.144 0.379 ± 0.171 0.852 ± 0.064
0.367 ± 0.185 0.237 ± 0.161 0.390 ± 0.165 0.858 ± 0.054
Chi-Squared 0.583 ± 0.1850 0.646 ± 0.118 0.529 ± 0.158 0.335 ± 0.212 0.871 ± 0.136 – –
0.591 ± 0.195 0.668 ± 0.130 0.514 ± 0.159 0.289 ± 0.193 0.874 ± 0.149
0.574 ± 0.217 0.668 ± 0.135 0.497 ± 0.167 0.286 ± 0.194 0.875 ± 0.148
SVM-RFE 0.233 ± 0.097 0.184 ± 0.089 0.226 ± 0.107 0.323 ± 0.087 0.141 ± 0.068 0.302 ± 0.142 –
0.219 ± 0.100 0.233 ± 0.089 0.251 ± 0.086 0.272 ± 0.064 0.184 ± 0.07 0.269 ± 0.076
0.217 ± 0.089 0.201 ± 0.089 0.227 ± 0.098 0.277 ± 0.059 0.193 ± 0.084 0.273 ± 0.097
LL21 0.618 ± 0.224 0.617 ± 0.215 0.552 ± 0.236 0.414 ± 0.215 0.584 ± 0.202 0.200 ± 0.088 0.908 ± 0.056
0.606 ± 0.22 0.613 ± 0.229 0.539 ± 0.241 0.353 ± 0.185 0.574 ± 0.203 0.206 ± 0.099 0.887 ± 0.064
0.546 ± 0.253 0.565 ± 0.242 0.475 ± 0.235 0.324 ± 0.186 0.541 ± 0.209 0.184 ± 0.084 0.856 ± 0.087
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Table 4 Results obtained with the FS ensemble with subset size defined by RPT using β = 0.1 (upper values), β = 1 (middle values)
and β = 10 (bottom values) for different classifiers. Results are averaged over 10 × 5 stratified cross validation, for each time window,
using ADNI data
AUC Sensitivity Specificity Stability # Features
2Y NB 0.758 ± 0.00 0.599 ± 0.01 0.834 ± 0.00 1.0 ± 0.0 2
0.839 ± 0.00 0.744 ± 0.01 0.779 ± 0.01 0.982 ± 0.01 17
0.864 ± 0.00 0.791 ± 0.01 0.819 ± 0.01 0.912 ± 0.01 35
SVM Poly 0.460 ± 0.08 0.323 ± 0.03 0.933 ± 0.00 1.0 ± 0.0 2
0.849 ± 0.00 0.758 ± 0.01 0.797 ± 0.01 0.982 ± 0.01 17
0.889 ± 0.01 0.789 ± 0.02 0.838 ± 0.01 0.913 ± 0.02 30
SVM RBF 0.770 ± 0.00 0.571 ± 0.02 0.829 ± 0.01 1.0 ± 0.0 2
0.864 ± 0.01 0.758 ± 0.02 0.825 ± 0.01 0.978 ± 0.02 22
0.891 ± 0.01 0.777 ± 0.02 0.841 ± 0.01 0.913 ± 0.02 30
DT 0.588 ± 0.02 0.446 ± 0.03 0.732 ± 0.03 1.0 ± 0.0 2
0.706 ± 0.02 0.574 ± 0.04 0.839 ± 0.01 0.934 ± 0.02 38
0.715 ± 0.03 0.568 ± 0.06 0.861 ± 0.01 0.919 ± 0.02 34
LR 0.769 ± 0.00 0.637 ± 0.01 0.784 ± 0.00 1.0 ± 0.0 2
0.846 ± 0.01 0.732 ± 0.03 0.821 ± 0.01 0.978 ± 0.02 22
0.882 ± 0.01 0.727 ± 0.02 0.848 ± 0.01 0.913 ± 0.02 32
3Y NB 0.772 ± 0.01 0.521 ± 0.01 0.901 ± 0.00 1.0 ± 0.0 2
0.859 ± 0.00 0.761 ± 0.01 0.804 ± 0.01 0.985 ± 0.01 22
0.872 ± 0.00 0.775 ± 0.02 0.829 ± 0.01 0.889 ± 0.01 30
SVM Poly 0.734 ± 0.01 0.0 ± 0.0 1.0 ± 0.0 1.0 ± 0.0 2
0.879 ± 0.00 0.584 ± 0.02 0.925 ± 0.01 0.927 ± 0.01 37
0.876 ± 0.01 0.626 ± 0.02 0.912 ± 0.01 0.780 ± 0.02 55
SVM RBF 0.777 ± 0.01 0.169 ± 0.02 0.982 ± 0.01 1.0 ± 0.0 2
0.871 ± 0.01 0.614 ± 0.01 0.924 ± 0.01 0.985 ± 0.02 22
0.872 ± 0.01 0.619 ± 0.02 0.914 ± 0.01 0.942 ± 0.01 25
DT 0.602 ± 0.02 0.463 ± 0.02 0.742 ± 0.02 1.0 ± 0.0 2
0.704 ± 0.02 0.603 ± 0.03 0.804 ± 0.02 0.959 ± 0.03 22
0.719 ± 0.02 0.622 ± 0.03 0.816 ± 0.01 0.890 ± 0.02 33
LR 0.777 ± 0.01 0.505 ± 0.01 0.920 ± 0.00 1.0 ± 0.0 2
0.864 ± 0.01 0.658 ± 0.02 0.889 ± 0.01 0.985 ± 0.02 22
0.864 ± 0.01 0.658 ± 0.02 0.889 ± 0.01 0.985 ± 0.02 22
4Y NB 0.858 ± 0.03 0.779 ± 0.01 0.820 ± 0.01 0.937 ± 0.02 15
0.891 ± 0.01 0.775 ± 0.01 0.844 ± 0.02 0.925 ± 0.02 36
0.886 ± 0.00 0.789 ± 0.01 0.819 ± 0.01 0.895 ± 0.02 32
SVM Poly 0.849 ± 0.01 0.706 ± 0.02 0.824 ± 0.02 0.937 ± 0.02 15
0.904 ± 0.00 0.757 ± 0.02 0.884 ± 0.01 0.846 ± 0.02 36
0.908 ± 0.01 0.757 ± 0.02 0.884 ± 0.01 0.847 ± 0.02 45
SVM RBF 0.871 ± 0.01 0.702 ± 0.01 0.887 ± 0.01 0.937 ± 0.02 15
0.901 ± 0.00 0.754 ± 0.02 0.863 ± 0.02 0.925 ± 0.02 10
0.905 ± 0.01 0.758 ± 0.01 0.873 ± 0.03 0.829 ± 0.03 70
DT 0.735 ± 0.03 0.708 ± 0.05 0.761 ± 0.02 0.937 ± 0.02 15
0.735 ± 0.03 0.708 ± 0.05 0.761 ± 0.02 0.937 ± 0.02 15
0.735 ± 0.03 0.708 ± 0.05 0.761 ± 0.02 0.937 ± 0.02 17
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selects the pair of features and classifier with the highest
RPT), the results reported in the next subsections use NB,
and LR, to find the best subsets of features for the 3 and
4-years time windows, and the 2-years time window,
respectively.
Wrapper optimization of features combining stability and
predictability
Figure 3 illustrates how feature stability and predictabil-
ity vary with the size of the subset of features (k), for
each time window in ADNI (left panel, Fig. 3) and CCC
(right panel, Fig. 3) data, using NB (3 and 4-years time
windows) and LR (2-years time window). Similar results
were obtained for the remaining classifiers [See Add-
itional file 3]. We note that features are ranked accord-
ing to FS ensemble output.
Our results show that stability is more sensitive to the
size of the subset of features than AUC (Fig. 3), corrob-
orating previous studies [8, 38]. The stability curve is in
general characterized by an initial fast growth with
widely-dispersed values, having multiple local max-
imums, followed by a short plateau until it declines
again. This large initial variance of stability values re-
flects the differences in the highest ranked features when
using different FS methods and different data (CV folds).
In this context, stability is an important factor to con-
sider when optimizing the size of the subset of features
to guarantee we choose (the number of) features that
are consistently selected amongst cross-validation folds
and feature selection methods.
The AUC curve, on the other hand, is characterized by
a smooth and gradual growth until stabilization and, for
larger subsets of features, by a slight decrease. Yet, sensi-
tivity and specificity values show an accentuate variation
with respect to the size of the subset of features (k). The
small variation in AUC values is due to the synchronised
increases and decreases in sensitivity and specificity (or
vice-versa). In this context, we decided not to use AUC
alone to assess predictability when computing RPT, since
it would select thresholds for which either the sensitivity
or specificity values were very low. Instead, we combined
AUC with sensitivity and specificity (1) in order to pick
thresholds with a good compromise between both evalu-
ation metrics. This is in accordance with our aim of
learning a model as accurate as possible in classifying
both converting and non-converting patients.
RPT thresholds are strongly affected by the peaks of
stability when β = 0.1 and β = 1 (Fig. 3). When β = 0.1,
the respective thresholds match the first stability max-
imum, using ADNI data (left panel, Fig. 3). Due to the
high stability scores, even when β = 1, stability plays the
main role in determining the threshold value. Setting β
= 10 mitigates this effect as the emergent cut-offs points
(RPT thresholds) show a good trade-off between perfor-
mances of stability and the remaining evaluation metrics.
Statistical significant differences are found between the
classification results obtained when learning the model
with subsets of features delimited by each of the
three RPT values (β = {0.1, 1, 10}) for all time win-
dows and in both datasets (p < 0.0005, Friedman
Test), except for the 2-years time window, using CCC
data (p < 0.202, Friedman Test). In particular, β = 10
outperforms β = 0.1 (p < 0.005), across all time win-
dows and datasets, and β = 1 (p < 0.005) in the 3 and
4-years time windows using ADNI and CCC data, re-
spectively. No differences are found between β = 10
and β = 1 in the remaining datasets (p > 0.022). We
thus considered RPT with β = 10 as the optimal
threshold to ascertain the size of the subset of fea-
tures. The best feature selection threshold finds sub-
sets of size around 30 and 20 features for all time
windows, using ADNI and CCC data, respectively.
Comparing base feature selection methods with the
ensemble
Tables 6 and 7 report the results obtained when using the
proposed FS ensemble, each base FS method, and the
original set of features to learn the prognostic model, in
ADNI and CCC data, respectively. Classification results
(computed according to (1)) are statistically significant for
all time windows, as assessed by the Friedman Test
[66] (p < 0.0005). Pairwise comparisons (using the
Wilcoxon Signed Rank Test [66]) were then performed
(with Bonferroni correction for multiple testing) to com-
pare ensemble learning with the base FS methods and in
the absence of feature selection. Results are significantly
weaker when the entire set of features is used, instead of
the subset given by the FS ensemble, over all time win-
dows and using ADNI and CCC data (p < 0.005, Wilcoxon
Table 4 Results obtained with the FS ensemble with subset size defined by RPT using β = 0.1 (upper values), β = 1 (middle values)
and β = 10 (bottom values) for different classifiers. Results are averaged over 10 × 5 stratified cross validation, for each time window,
using ADNI data (Continued)
AUC Sensitivity Specificity Stability # Features
LR 0.870 ± 0.01 0.745 ± 0.02 0.862 ± 0.01 0.937 ± 0.02 15
0.870 ± 0.01 0.745 ± 0.02 0.862 ± 0.01 0.937 ± 0.02 15
0.869 ± 0.01 0.751 ± 0.02 0.846 ± 0.01 0.905 ± 0.02 25
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Table 5 Results obtained with the FS ensemble with subset size defined by RPT using β = 0.1 (upper values), β = 1 (middle values)
and β = 10 (bottom values) for different classifiers. Results are averaged over 10 × 5 stratified cross validation, for each time window,
using CCC data
AUC Sensitivity Specificity Stability # Features
2Y NB 0.803 ± 0.01 0.746 ± 0.01 0.681 ± 0.00 1.0 ± 0.0 9
0.829 ± 0.00 0.771 ± 0.01 0.733 ± 0.01 0.971 ± 0.03 18
0.829 ± 0.00 0.765 ± 0.01 0.744 ± 0.01 0.936 ± 0.01 20
SVM Poly 0.815 ± 0.01 0.863 ± 0.01 0.767 ± 0.01 1.0 ± 0.0 9
0.839 ± 0.00 0.789 ± 0.01 0.767 ± 0.01 0.965 ± 0.03 19
0.841 ± 0.00 0.788 ± 0.01 0.758 ± 0.01 0.936 ± 0.01 20
SVM RBF 0.820 ± 0.00 0.803 ± 0.02 0.673 ± 0.01 1.0 ± 0.0 9
0.841 ± 0.00 0.771 ± 0.01 0.765 ± 0.01 0.965 ± 0.03 19
0.841 ± 0.00 0.771 ± 0.01 0.765 ± 0.01 0.965 ± 0.03 19
DT 0.616 ± 0.02 0.445 ± 0.03 0.786 ± 0.01 1.0 ± 0.0 9
0.643 ± 0.02 0.578 ± 0.05 0.633 ± 0.03 0.918 ± 0.02 1
0.643 ± 0.02 0.578 ± 0.05 0.633 ± 0.03 0.918 ± 0.02 1
LR 0.811 ± 0.01 0.752 ± 0.02 0.726 ± 0.01 1.0 ± 0.0 9
0.811 ± 0.01 0.752 ± 0.02 0.726 ± 0.01 1.0 ± 0.0 9
0.821 ± 0.01 0.765 ± 0.01 0.765 ± 0.01 0.936 ± 0.01 20
3Y NB 0.833 ± 0.00 0.749 ± 0.01 0.735 ± 0.01 1.0 ± 0.0 9
0.857 ± 0.00 0.779 ± 0.01 0.772 ± 0.01 0.966 ± 0.01 19
0.859 ± 0.00 0.778 ± 0.01 0.781 ± 0.01 0.950 ± 0.01 20
SVM Poly 0.844 ± 0.00 0.0 ± 0.0 1.0 ± 0.0 1.0 ± 0.0 9
0.872 ± 0.00 0.633 ± 0.01 0.886 ± 0.00 0.966 ± 0.02 19
0.873 ± 0.01 0.643 ± 0.01 0.874 ± 0.00 0.909 ± 0.02 25
SVM RBF 0.842 ± 0.00 0.582 ± 0.01 0.870 ± 0.01 1.0 ± 0.0 9
0.873 ± 0.00 0.608 ± 0.01 0.891 ± 0.00 0.966 ± 0.02 19
0.874 ± 0.00 0.612 ± 0.01 0.895 ± 0.01 0.950 ± 0.02 20
DT 0.664 ± 0.02 0.556 ± 0.03 0.773 ± 0.03 1.0 ± 0.0 9
0.686 ± 0.02 0.587 ± 0.03 0.784 ± 0.02 0.986 ± 0.02 12
0.686 ± 0.02 0.587 ± 0.03 0.784 ± 0.02 0.986 ± 0.02 12
LR 0.838 ± 0.01 0.619 ± 0.02 0.859 ± 0.00 1.0 ± 0.0 9
0.838 ± 0.01 0.619 ± 0.02 0.859 ± 0.01 1.0 ± 0.0 9
0.853 ± 0.01 0.635 ± 0.01 0.859 ± 0.01 0.950 ± 0.02 20
4Y NB 0.852 ± 0.00 0.796 ± 0.01 0.768 ± 0.01 1.0 ± 0.0 9
0.852 ± 0.00 0.796 ± 0.01 0.768 ± 0.01 1.0 ± 0.0 9
0.868 ± 0.00 0.793 ± 0.01 0.788 ± 0.01 0.955 ± 0.02 19
SVM Poly 0.853 ± 0.00 0.821 ± 0.01 0.720 ± 0.00 1.0 ± 0.0 9
0.872 ± 0.00 0.775 ± 0.01 0.821 ± 0.01 0.959 ± 0.2 20
0.872 ± 0.00 0.775 ± 0.01 0.821 ± 0.01 0.959 ± 0.02 20
SVM RBF 0.858 ± 0.00 0.754 ± 0.01 0.798 ± 0.00 1.0 ± 0.0 9
0.858 ± 0.00 0.754 ± 0.01 0.798 ± 0.00 1.0 ± 0.0 9
0.871 ± 0.00 0.763 ± 0.01 0.820 ± 0.01 0.949 ± 0.03 16
DT 0.675 ± 0.01 0.641 ± 0.02 0.713 ± 0.01 1.0 ± 0.0 2
0.675 ± 0.01 0.641 ± 0.02 0.713 ± 0.01 1.0 ± 0.0 2
0.682 ± 0.02 0.655 ± 0.03 0.717 ± 0.01 0.937 ± 0.04 14
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Table 5 Results obtained with the FS ensemble with subset size defined by RPT using β = 0.1 (upper values), β = 1 (middle values)
and β = 10 (bottom values) for different classifiers. Results are averaged over 10 × 5 stratified cross validation, for each time window,
using CCC data (Continued)
AUC Sensitivity Specificity Stability # Features
LR 0.852 ± 0.00 0.737 ± 0.01 0.801 ± 0.01 1.0 ± 0.0 9
0.852 ± 0.00 0.737 ± 0.01 0.801 ± 0.01 1.0 ± 0.0 9
0.742 ± 0.01 0.742 ± 0.01 0.803 ± 0.01 0.929 ± 0.01 15
Fig. 3 Stability and classification performance for subsets of features with different sizes (k) following 10 × 5 stratified CV and using time windows
of 2-years (upper), 3-years (middle) and 4-years (bottom) obtained with ADNI (left panel) and CCC (right panel) data, using the NB and LR. RPT
thresholds with β set as 0.1, 1 and 10 are illustrated
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signed-rank tests). Apart from the superior classification
results, using fewer features prevents overfitting, promotes
generalization, and increases model interpretability.
MRMR also lead to statistically worse classification results
than the FS ensemble for the 3 and 4-years time windows,
using ADNI and CCC datasets (p < 0.005). ReliefF outper-
forms the FS ensemble while Chi-Squared underperforms
it in the 4-years time window (p < 0.005), using ADNI
data. No statistically significant differences are found be-
tween the ensemble and the remaining methods MIM,
CMIM, and LL21 (p > 0.009). Tackling redundancy be-
tween features while selecting them seems to be a strength
for the problem under study as this is a common charac-
teristic of MIM, CMIM, and LL21, which perform as good
as the ensemble. Regarding CCC data, the ensemble ap-
proach outperforms Chi-Squared and LL21 for the 3-years
Table 6 Results obtained with the entire set of features, the FS ensemble and the individual FS algorithms for time-windows of a) 2-
years, b) 3-years and c) 4-years, using ADNI data. Results are averaged over the 10 × 5 stratified cross validation with subset size
defined by the optimized RPT threshold (β = 10)
Ensemble ReliefF MIM CMIM MRMR Chi-Squared LL21 All features
2-years windows AUC 0.882 ± 0.01 0.861 ± 0.01 0.865 ± 0.01 0.882 ± 0.01 0.859 ± 0.01 0.864 ± 0.0 0.851 ± 0.01 0.860 ± 0.01
Sensitivity 0.727 ± 0.02 0.758 ± 0.02 0.754 ± 0.03 0.736 ± 0.03 0.749 ± 0.02 0.771 ± 0.01 0.752 ± 0.01 0.594 ± 0.02
Specificity 0.848 ± 0.01 0.826 ± 0.01 0.833 ± 0.02 0.847 ± 0.01 0.803 ± 0.00 0.815 ± 0.01 0.821 ± 0.01 0.903 ± 0.01
Stability 0.913 ± 0.02 0.888 ± 0.02 0.907 ± 0.02 0.892 ± 0.02 1.0 ± 0.0 1.0 ± 0.0 0.837 ± 0.02 –
# Features 32 8 25 32 7 4 11 79
3-years windows AUC 0.872 ± 0.004 0.857 ± 0.00 0.871 ± 0.00 0.872 ± 0.00 0.863 ± 0.00 0.859 ± 0.01 0.868 ± 0.00 0.835 ± 0.01
Sensitivity 0.775 ± 0.018 0.784 ± 0.01 0.778 ± 0.01 0.782 ± 0.02 0.728 ± 0.01 0.776 ± 0.02 0.793 ± 0.02 0.714 ± 0.02
Specificity 0.829 ± 0.011 0.817 ± 0.01 0.831 ± 0.01 0.827 ± 0.00 0.805 ± 0.01 0.841 ± 0.01 0.804 ± 0.01 0.782 ± 0.01
Stability 0.889 ± 0.013 0.892 ± 0.02 0.913 ± 0.02 0.941 ± 0.01 0.789 ± 0.02 0.986 ± 0.02 0.944 ± 0.03 –
# Features 30 15 23 29 70 10 45 79
4-years windows AUC 0.886 ± 0.003 0.876 ± 0.00 0.881 ± 0.00 0.883 ± 0.01 0.867 ± 0.01 0.870 ± 0.01 0.872 ± 0.01 0.853 ± 0.006
Sensitivity 0.789 ± 0.007 0.788 ± 0.01 0.799 ± 0.01 0.798 ± 0.01 0.732 ± 0.01 0.761 ± 0.01 0.792 ± 0.02 0.705 ± 0.009
Specificity 0.819 ± 0.013 0.817 ± 0.02 0.818 ± 0.01 0.831 ± 0.01 0.815 ± 0.01 0.837 ± 0.01 0.819 ± 0.01 0.831 ± 0.017
Stability 0.895 ± 0.023 0.839 ± 0.02 0.881 ± 0.02 0.899 ± 0.02 0.906 ± 0.05 0.93 ± 0.02 0.923 ± 0.03 –
# Features 32 22 23 33 75 23 50 79
Table 7 Results obtained with the entire set of features, the FS ensemble and the individual FS algorithms for time-windows
of a) 2-years, b) 3-years and c) 4-years, using CCC data. Results are averaged over the 10 × 5 stratified cross validation with
subset size defined by the optimized RPT threshold (β = 10)
Ensemble ReliefF MIM CMIM MRMR Chi-Squared LL21 All features
2-years windows AUC 0.821 ± 0.00 0.813 ± 0.01 0.806 ± 0.01 0.817 ± 0.01 0.827 ± 0.01 0.820 ± 0.01 0.809 ± 0.01 0.814 ± 0.01
Sensitivity 0.738 ± 0.02 0.744 ± 0.03 0.743 ± 0.02 0.735 ± 0.03 0.757 ± 0.02 0.742 ± 0.02 0.750 ± 0.02 0.385 ± 0.04
Specificity 0.765 ± 0.01 0.758 ± 0.01 0.762 ± 0.01 0.767 ± 0.01 0.764 ± 0.01 0.763 ± 0.01 0.746 ± 0.01 0.920 ± 0.01
Stability 0.936 ± 0.01 0.889 ± 0.03 0.928 ± 0.03 0.872 ± 0.03 0.975 ± 0.02 0.894 ± 0.02 0.986 ± 0.02 –
# Features 20 14 16 25 16 20 12 40
3-years windows AUC 0.859 ± 0.00 0.860 ± 0.00 0.861 ± 0.00 0.853 ± 0.04 0.855 ± 0.00 0.861 ± 0.00 0.863 ± 0.00 0.853 ± 0.00
Sensitivity 0.778 ± 0.01 0.779 ± 0.01 0.778 ± 0.01 0.778 ± 0.01 0.762 ± 0.01 0.776 ± 0.01 0.775 ± 0.01 0.734 ± 0.01
Specificity 0.781 ± 0.01 0.778 ± 0.01 0.784 ± 0.01 0.779 ± 0.01 0.785 ± 0.01 0.786 ± 0.00 0.792 ± 0.00 0.819 ± 0.00
Stability 0.950 ± 0.02 0.922 ± 0.03 0.939 ± 0.01 0.885 ± 0.03 0.767 ± 0.03 0.992 ± 0.02 0.996 ± 0.02 –
# Features 20 18 18 19 35 20 18 40
4-years windows AUC 0.868 ± 0.00 0.868 ± 0.00 0.868 ± 0.00 0.865 ± 0.00 0.850 ± 0.00 0.869 ± 0.00 0.865 ± 0.00 0.859 ± 0.00
Sensitivity 0.793 ± 0.01 0.773 ± 0.01 0.774 ± 0.01 0.795 ± 0.01 0.785 ± 0.01 0.793 ± 0.01 0.789 ± 0.01 0.729 ± 0.01
Specificity 0.788 ± 0.00 0.792 ± 0.01 0.791 ± 0.00 0.789 ± 0.01 0.782 ± 0.01 0.789 ± 0.00 0.789 ± 0.00 0.841 ± 0.01
Stability 0.955 ± 0.02 0.908 ± 0.02 0.951 ± 0.01 0.862 ± 0.3 0.802 ± 0.03 0.923 ± 0.02 0.909 ± 0.02 –
# Features 19 18 16 18 12 16 15 40
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time window (p < 0.007). No statistically significant differ-
ences are found in the remaining methods (p > 0.037)
when using CCC data.
In sum, although the FS ensemble approach does
not outperform all base FS methods, it achieves com-
petitive, or even superior, results in all experiments,
being defeated only by ReliefF in the 4-years time
window (ADNI).
Features found as best prognostic predictors
Tables 8 and 9 show the top 30 and 20 ranked features
found by the proposed FS ensemble (RPT threshold with
β = 10), for each time window, using ADNI and CCC
data, respectively. Features are sorted by relevance
(ranking position, per time window, is indicated within
brackets). Most features match across time windows on
both datasets although with slight differences on the
ranking positions.
A direct comparison between the most frequently
selected neuropsychological measures in ADNI and
CCC datasets is hard to establish mainly because
they do not have a common neuropsychological bat-
tery. As an example, Trail Making Test (TMT) and
Rey Auditory Verbal Learning Test (RAVLT) are
amongst the highest ranked features in ADNI but
could not be evaluated in CCC. While TMT was re-
moved due to missing values constraints (preprocess-
ing step), RAVLT does not make part of the CCC
neuropsychological battery. Notwithstanding, most of
the top selected NPTS in both datasets assess the
same cognitive domains, supporting the concordance
between the results. For instance, both TMT – Part
A and Cancelation Task – A’s, top selected NPTs in
ADNI and CCC, respectively, evaluate execution
times. Moreover, tests to gauge memory impairment,
such as Forgetting Index, Logical Memory (LM),
RAVLT and Verbal Paired-Associate Learning
(VPAL) are amongst the top selected NPTS in CCC
and/or ADNI datasets. In addition, these NPTs have
also been recognized as strong predictors of conver-
sion from MCI to dementia due to Alzheimer’s
Disease [8, 40].
Table 8 Top selected features using the ensemble approach
with ADNI data (RPT threshold with β set as 10). Ranking
positions of each feature are reported within brackets for the
2,3, and 4 years time windows, respectively
Common features across all time windows
Trail Making Test (Part B) - time
(1,1,1)
AVDELTOT: AVLT Recognition
(14,15,20)
Forgetting Index (2,2,2) Boston Test Naming (15,12,11)
AVTOT15: RAVLT 15 (3,3,4) ADAS-Cog Q4: Delayed word
recall (16,17,16)
ADAS-Cog Total 13 (4,4,5) ADAS-Cog Q8: Word recognition
(17,16,15)
Trail Making Test (Part A) -
time (5,5,3)
MMSE (total) (18,20,17)
ADAS-Cog Total 11 (6,7,8) ADAS-Cog Q1: Word recall
(19,21,19)
AVTOT6: RAVLT 6 (7,6,7) Letter Fluency (20,22,21)
Logical Memory Immediate
(8,8,9)
Age (21,18,18)
Category Fluency (9,10,6) Years of symptoms (22,19,22)
AVDEL30: RAVLT delay
(10,9,10)
CDR: Orientation (25,26,26)
FAQ: Activities of Daily
Living (11,13,13)
CDR: Home (26,23,23)
Logical Memory Delayed
(12,11,12)
AVTOTB: AVLT Interference
(27,25,25)
MOCADMDL (13,14,15)
Common features across one or two time windows
ADAS-Cog Q7: Orientation
(23,24,-)
MMORIENTOT (29,-,-)
GDS (24,27,-) ADAS-Cog Q13: Number
cancelation (−,29,-)
Years of formal education
(28,-,27)
CDR: Judgment and problem
solving (−,-,29)
MMDLRECALL (−,28,24) CDR: Community Affair (−,-,30)
Table 9 Top selected features using the ensemble approach
with CCC data (RPT threshold with β set as 10). Ranking
positions of each feature are reported within brackets for the
2,3, and 4 years time windows, respectively
Common features across all time windows
Forgetting Index (1,1,1) Verbal Paired-Associate Learning
– Difficult (10,11,11)
Verbal Paired-Associate
Learning – Total (2,2,2)
Verbal Paired-Associate Learning
– Easy (11,10,10)
Cancelation Task – A’s
time (3,4,6)
Word Recall (Total) (12,12,12)
Logical Memory Immediate
A free recal (4,3,5)
Orientation (Total) (13,14,14)
Age (first symptoms) (5,8,7) Raven Progressive Matrices
(15,14,14)
Category Fluency (6,5,4) Years of formal education
(16,17,16)
Age (7,6,3) Word Recall – Free recall
(18,19,19)
Logical Memory A with
Interference- free recall
(8,7,9)
Cancelation Task – A’s total
(19,18,18)
Logical Memory A
Immediate Cued (9,9,8)
–
Common features across one or two time windows
Interpretation of proverbs -
(Verbal Abstraction) (17,-,20)
Calculation (19,-,-)
Information (−,16,17) Orientation – Temporal (20,20,-)
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Discussion
The results demonstrate the effectiveness of the pro-
posed feature selection ensemble combining stability
and predictability (FSE-StabPred) to 1) identify subsets
of stable and relevant predictors from a consensus of
multiple FS methods using baseline NPTs and 2) learn
reliable prognostic models of conversion from MCI to
AD using these subsets of features. The prognostic
models learnt from these features outperformed the
models trained without FS and achieved competitive re-
sults when compared to commonly used FS algorithms
and even superior sometimes. In fact, the FS ensemble
was only beaten by ReliefF in the 4-years time window,
using ADNI data (Tables 6 and 7). In this context, in our
opinion, the ensemble approach should be preferred to
individual feature selectors. On the one hand, it com-
bines features coming from multiple methods with dif-
ferent search criteria thus being more robust. On the
other hand, it releases users from deciding the most suit-
able FS method to use for a given task, without com-
promising results. In addition, by running the
ensemble-based approach using different classifiers to
find the best subset of features (Tables 4 and 5) we aim
to guarantee that we choose the subset of features using
the classifier better fitting the data under study. This
classifier should then be used to learn the final prognos-
tic model using the selected features. In this work, NB,
and LR, were the best performing classifiers for the 3
and 4-years time windows, and the 2-years time window,
respectively.
A recent comprehensive review on cognitive measures
to predict conversion from MCI to AD [40] reports that
individual neuropsychological tests show high specificity
scores more often than high sensitivity scores when pre-
dicting progression from MCI to Alzheimer’s Disease.
Our results corroborate this trend. In fact, for small sub-
sets of features (less than 5 or 10 features for CCC and
ADNI data, respectively) high specificity (and low sensi-
tivity) scores are obtained in most time windows and
datasets (Fig. 3). The large discrepancy between sensitiv-
ity and specificity attained with small subsets of features
strengths the importance of our study: using sophisti-
cated FS approaches and assessing a large number of
neuropsychological measures together [46]. In fact,
studying the predictive power of single (or small combi-
nations of ) NPTs [40] may not be sufficient to describe
the complexity of this neurodegenerative process [46].
Moreover, as evidenced in Fig. 3, stability had a wide
variation with the size of the subset of features used to
learn the prognostic models, superior to AUC, corrobor-
ating previous studies [8, 38]. This stability’ variation re-
flects the differences in the highest ranked features
when using different FS methods and different data (CV
folds). With this in mind, stability is a key factor when
optimizing the size of the subset of features to guarantee
we choose (the number of ) features that are constantly
selected amongst cross-validation folds and features se-
lection methods.
In what concerns prognostic prediction within time
windows, results could not evidence a correlation be-
tween the choice of the most predictive subset of fea-
tures and the time to conversion. The classification
performance of the prognostic model improves through-
out the time window growth, both with ADNI and CCC
data (Ensemble column, Tables 6 and 7). This corrobo-
rates our previous findings [12] where prognostic models
learnt with longer (4 and 5-years) time windows already
achieved superior predictive performances. However, the
behaviour of stability and classification performance
curves, as well as the number of selected features, are
similar across all time windows (Fig. 3). Furthermore,
top-ranked features (Tables 8 and 9) are identical across
the time windows.
Many of the highest ranked NPTs have been identified
in the literature as being strong predictors of conversion
from MCI to dementia due to Alzheimer’s Disease [8,
40]. Episodic memory (the ability to recall events that
are specific to a time and place) has been seen as a hall-
mark risk feature for later development of AD [8, 67,
68]. It is usually the first domain to decline, with impair-
ments being noticed up to 10 years before diagnosis [67,
69, 70], in population-based studies of preclinical AD.
Episodic memory can be assessed using the Logical
Memory (LM) test and through learning tasks evaluated
in the RAVLT and Verbal Paired-Associate Learning
(VPAL) test [40]. VPAL test has been effective in detect-
ing MCI patients who will convert to dementia, particu-
larly AD [67, 71]. In our study, sub-scores of the RAVLT
and LM immediate, and three LM measures (immediate
and delayed tasks) and VPAL test, are among the top-10
selected measures on ADNI and CCC, respectively.
Moreover, forgetting index, a primarily test of memory
used in [68], is the most relevant feature on CCC and
the second most relevant feature on ADNI, for all time
windows. This index evaluates the information success-
fully encoded, but lost in delayed recall and not recov-
ered with the cued condition. Category verbal fluency
has been identified as a strong predictor of conversion
in our study (both in ADNI and CCC data), corroborat-
ing other researchers’ findings [45, 67]. Despite on differ-
ent tests, execution times are considered discriminative
of MCI patients who will (or not) convert to AD on
ADNI (Trail Making Test - Part A) and CCC (Cancel-
ation Task – A’s) data. Trail Making Test - time (Part A
and B), ranked at least on the 5th position on ADNI
dataset in our study, was also identified as a relevant
predictor in [8]. Moreover, this test has been found to
decline together with category fluency [67]. Our results
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support this finding, as both tests were on the top 10
features on both CCC and ADNI data.
Importantly, our feature selection ensemble approach
proved to be valuable to identify predictors of MCI con-
version do AD on two quite different datasets in two dif-
ferent countries. Furthermore, ADNI data has already
been considered not representative of USA population,
including mostly highly educated subjects [8, 72], and
from this point of view, CCC is closer to the general
Portuguese population. Besides demographic differences
in these two cohorts, as well as the number and specific
neuropsychological tests included, the proposed ap-
proach is able to identify equivalent (reflecting the same
cognitive abilities known to be relevant for prediction of
conversion to dementia in previous clinical studies)
neuropsychological measures which are ranked top in
both datasets.
Other researchers have applied machine learning strat-
egies to automatically reduce the number of neuro-
psychological measures used in AD-related studies [6–8,
45]. Genetic algorithms have been used [7, 45] to choose
subsets of relevant NPTs for prognostic prediction in
AD. Our results are not only slightly superior regarding
classification performance but select neuropsychological
measures more in line with the literature [7] while using
a larger patients’ cohort [45]. The combination of stabil-
ity and feature selection was studied by Ye et al. [8]. The
authors used sparse logistic regression with stability se-
lection to find strong predictors from baseline ADNI
measurements of demographic, genetic, cognitive and
MRI data. Our feature selection ensemble approach (and
classification model) achieved higher AUC values while
using only neuropsychological data.
Conclusions
Neuropsychological tests have proven their ability in dis-
criminating between different stages of cognitive impair-
ment [12, 40, 44]. However, the vast subjectivity and
volume of the NPTs assessed in the clinical practice
hampers the classification task. Feature selection is use-
ful not only to automatically select the best NPTs to pre-
dict whether a MCI patient is likely (or not) to become
demented in the future but also to improve model inter-
pretability and classifier performance, which is often
constraint by a small number of learning examples.
We proposed a heterogeneous ensemble approach to
tackle feature selection where stability and predictability
are combined to find the optimal subset of features. A
subset of stable features is thus reached by choosing fea-
tures selected from a consensus of different FS methods
and keeping the top-selected features that optimize stabil-
ity and predictability. Subsets of features may be (option-
ally) optimized by tuning the classifier used to assess
predictability to the data under study. Results showed that
the proposed FS ensemble is suitable to optimize the set
of neuropsychological tests required to learn trustworthy
prognostic models in AD. Although the ensemble ap-
proach did not outperform all base FS methods (run indi-
vidually), its results were competitive in all experiments
and even superior to base FS methods sometimes. As
such, it is worth using the proposed FS ensemble ap-
proach as performance is not compromised, there is no
need to choose the FS algorithm more suitable to the
problem at hand, and the set of features result from a con-
sensus of FS methods.
Our study has advantages over others [7, 8, 40] since it
uses two large patients cohorts (one publicly available,
ADNI, and a private Portuguese cohort, CCC) to valid-
ate the approach, evaluates the stability of the reduced
subsets of features (its sensitivity to data perturbation),
and considers a more significant number of baseline
tests of cognitive functioning (total of 79 and 40 features
from ADNI and CCC, respectively).
ENDNOTES
a Data used in preparation of this article were obtained
from the Alzheimer’s Disease Neuroimaging Initiative
(ADNI) database (adni.loni.usc.edu). As such, the in-
vestigators within the ADNI contributed to the design
and implementation of ADNI and/or provided data
but did not participate in analysis or writing of this
report. A complete listing of ADNI investigators can
be found at: http://adni.loni.usc.edu/wp-content/up-
loads/how_to_apply/ADNI_Acknowledgement_List.pdf
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used in the ensemble, using CCC data. (DOCX 61 kb)
Additional file 3: Stability and classification performance of classification
models learnt with an incremental number of (ranked) features and using
NB, DT, LR, SVM Poly and SVM RBF, per time windows, using ADNI and
CCC data. RPT thresholds with β set as 0.1, 1 and 10 are illustrated.
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